Chiral Building Blocks in Asymmetric Synthesis -  - E-Book

Chiral Building Blocks in Asymmetric Synthesis E-Book

0,0
178,99 €

-100%
Sammeln Sie Punkte in unserem Gutscheinprogramm und kaufen Sie E-Books und Hörbücher mit bis zu 100% Rabatt.

Mehr erfahren.
Beschreibung

The work presents achievements in the field of preparation and applications of building blocks in asymmetric synthesis. An indispensable resource for every academic and industrial researcher working in the field.

Sie lesen das E-Book in den Legimi-Apps auf:

Android
iOS
von Legimi
zertifizierten E-Readern

Seitenzahl: 1055

Veröffentlichungsjahr: 2022

Bewertungen
0,0
0
0
0
0
0
Mehr Informationen
Mehr Informationen
Legimi prüft nicht, ob Rezensionen von Nutzern stammen, die den betreffenden Titel tatsächlich gekauft oder gelesen/gehört haben. Wir entfernen aber gefälschte Rezensionen.



Table of Contents

Cover

Title Page

Copyright

Preface

Foreword

1 Enantioselective Synthesis of Cyclopropenes

1.1 Introduction

1.2 Metal‐Catalyzed Enantioselective Syntheses of Cyclopropenes

1.3 Other Synthetic Routes and Derivatizations of Enantioenriched Cyclopropenes

1.4 Summary and Prospect

References

2 Chiral Heterocycles for Asymmetric Synthesis

2.1 Introduction

2.2 Small‐Ring Heterocycles

2.3 Medium‐Ring Aliphatic Heterocycles

2.4 Other Heterocyclic Building Blocks

2.5 Conclusions

References

3 Saturated Heterocycles as Chiral Auxiliaries

3.1 Introduction

3.2 Proline‐Derived Chiral Auxiliaries

3.3 2,5‐

trans

‐Disubstituted Pyrrolidines

3.4 Heterocyclic Hydrazones

3.5 Oxazolidine‐Based Chiral Auxiliaries

3.6 Camphor‐Based Chiral Heterocyclic Auxiliaries

3.7 Phosphonamide‐Based Chiral Auxiliaries

3.8 Schöllkopf's Chiral Auxiliaries and Related Heterocycles for the Asymmetric Synthesis of α‐Amino Acids

3.9 Conclusions

References

4

trans‐

1,2‐Diaminocyclohexane and Its Derivatives in Asymmetric Organocatalysis

4.1 Introduction

4.2

trans‐

1,2‐Diaminocyclohexane‐Based Organocatalysts

4.3 Application of

trans‐

1,2‐Diaminocyclohexane Derivatives in Asymmetric Organocatalysis

4.4 Conclusions

References

5 Diketopiperazines as Chiral Building Blocks

5.1 Introduction

5.2 A Brief Overview of the Synthesis of 2,5‐Diketopiperazines

5.3 2,5‐Diketopiperazines in Drug Synthesis

5.4 Natural Product Synthesis

5.5 Conclusions

References

6 Amino Acids as Chiral Building Blocks

6.1 Introduction

6.2 Chiral Substrates/Reagents

6.3 Chiral Auxiliaries

6.4 Oxazaborolidines

6.5 Organocatalysts

6.6 Conclusions

References

7 Carbohydrate‐Based Catalysts and Auxiliaries in Organic Synthesis

7.1 Chiral Auxiliaries

7.2 Chiral Catalysts

References

8 Monoterpenes as Chiral Building Blocks

8.1 Introduction

8.2 Acyclic Monoterpene Building Blocks

8.3 Monocyclic Terpene Building Blocks

8.4 Bicyclic Terpene Building Blocks

8.5 Conclusions

References

9 Diterpene Acids as Starting Materials for the Synthesis of Biologically Active Compounds

9.1 Zamoranic Acid 1 as a Precursor of Interesting Compounds

9.2

Ent

‐halimic Acid as a Precursor of Biologically Active Compounds and Other Interesting Derivatives

Acknowledgments

References

10 Alkaloids as Chiral Building Blocks, Auxiliaries, Ligands, and Molecular Diversity

10.1 Introduction

10.2 Ephedra Alkaloids

10.3 Tobacco Alkaloids (Nicotine and Anabasine)

10.4 Lupin Alkaloids

10.5

Cinchona

Alkaloids

10.6 Tropane Alkaloids

10.7 Alkaloids as Building Blocks in the Syntheses of Chiral Polymers and Their Application

Acknowledgments

References

11 Chiral Building Blocks for Total Steroid Synthesis and the Use of Steroids as Chiral Building Blocks in Organic Synthesis

11.1 Introduction

11.2 Chiral Building Blocks for the Construction of Steroids

11.3 Steroids as Chiral Building Blocks

References

12 Chiral Organophosphorus Compounds in Asymmetric Synthesis

12.1 Introduction

12.2 Organophosphorus Compounds with Incorporated Chiral Terpene Moieties

12.3 Organophosphorus Compounds with Axial Chirality

12.4 Chiral Aminophosphonic Acids and Their Analogs

12.5 Stereogenic Organophosphorus Compounds with P—N and/or P—O Bonds

12.6 Summary

References

13 Organosulfur Compounds as Chiral Building Blocks

13.1 State of the Art

13.2 Introduction

13.3 The Tradition

13.4 Ideas for the Future

13.5 Conclusions

References

14 Organoselenium Compounds as Chiral Building Blocks

14.1 Introduction

14.2 Asymmetric Selenofuctionalization Reactions Promoted by Electrophilic Selenium Reagents

14.3 Vinyl Selenones as Important Building Blocks in Asymmetric Processes

14.4 Asymmetric Synthesis by Michael‐Initiated Ring Closure Reactions from Vinyl Selenones

14.5 Functionalization of Vinyl Selenones of Carbohydrates and Nucleotides

14.6 Asymmetric Organocatalytic Transformations Starting with Vinyl Selenones

14.7 Conclusion

References

15 Allenes as Chiral Building Blocks in Asymmetric Synthesis

15.1 Introduction

15.2 Nucleophilic Addition and Substitution

15.3 Allenylzinc and Indium Reagents, Allenylsilanes and Allenylstannanes

15.4 Epoxidation, Aziridination, and Silacyclopropanation of Allenes

15.5 Nazarov Cyclization of Allenyl Vinyl Ketones

15.6 Nucleophilic Cyclization and Addition Promoted by Electrophiles

15.7 Cycloisomerization and Other Reactions Catalyzed by Transition Metals

15.8 Cycloaddition of Allenes

Acknowledgments

References

16 The Synthesis and Application of BINOL Derivatives as Effective Building Blocks for Catalysts Employed in Enantioselective Synthesis

16.1 Introduction

16.2 BINOL Derivatives with Free Hydroxyl Groups

16.3 Onium Salts as Charged Catalysts in PTC

16.4 Chiral Phosphoric Acids Derived from BINOL Platform

Acknowledgments

References

17 Chiral Acenes: Synthesis and Applications

17.1 Introduction

17.2 Chiral Carbo[

n

]helicenes

17.3 Twistacenes

17.4 Chiral Nanobelts

17.5 Concluding Remarks

References

18 2‐Aza‐21‐Carbaporphyrin in Construction of Chiral Supramolecular Assemblies

18.1 Preface

18.2 Monomers

18.3 Dimers and Oligomers

18.4 Summary and Outlook

References

19 Catenane, Rotaxane, and Molecular Knot Chiral Building Blocks

19.1 Introduction

19.2 Elements of Molecular Topology

19.3 Topological Chirality and Chiral Catenanes

19.4 Chiral [2]Rotaxanes

19.5 Topologically Chiral Molecular Knots

19.6 Catenanes, Rotaxanes, and Knots as Chiral Building Blocks

19.7 Conclusions

References

Index

End User License Agreement

List of Tables

Chapter 7

Table 7.1 The 1,4‐addition to oxazolidinone‐conjugated sugar‐auxiliaries.

Table 7.2 The 1,4‐addition to ester type sugar‐auxiliaries.

Table 7.3 The Diels–Alder reaction of crotonic acid esters bearing carbohydr...

Table 7.4 The asymmetric aldol reaction catalyzed by

135–139

.

List of Illustrations

Chapter 1

Scheme 1.1 Catalytic stereoselective functionalization of cyclopropenes.

Scheme 1.2 Asymmetric cyclopropenation of terminal alkynes with

catalyst....

Scheme 1.3 Asymmetric cyclopropenation of terminal alkynes with

.

Scheme 1.4 Asymmetric cyclopropenation of terminal alkynes with

.

Scheme 1.5 Enantioselective [2+1]‐cycloaddition reactions of ethyl diazoacet...

Scheme 1.6 Asymmetric cyclopropenation of terminal alkynes using

.

Scheme 1.7

‐catalyzed cyclopropenation of terminal alkynes with diacceptor ...

Scheme 1.8 First enantioselective synthesis of fluorinated cyclopropenes and...

Scheme 1.9 Macrocyclization via cyclopropenation of alkynes using copper cat...

Scheme 1.10 Iridium‐catalyzed enantioselective cyclopropenation of terminal ...

Scheme 1.11 Enantioselective cyclopropenation with a cobalt–porphyrin comple...

Scheme 1.12 Enantioselective cyclopropenation reaction catalyzed by a gold–s...

Scheme 1.13 Directed evolution catalysis for enantioselective synthesis of c...

Scheme 1.14 Enantioselective desymmetrization of bis‐pentafluorophenylesters...

Scheme 1.15 Synthesis of (

)‐pentalenene via Pauson–Khand cycloaddition invo...

Scheme 1.16 Post‐functionalization of enantioenriched mono‐substituted cyclo...

Chapter 2

Scheme 2.1 Sharpless' epoxidation in the total synthesis of (+)‐disparlure....

Scheme 2.2 Epoxidation of allyl alcohol yielding an industrial building bloc...

Scheme 2.3 Synthesis of epoxide building block 7 in the total synthesis of b...

Scheme 2.4 Organocatalytic epoxidation of alkenes. DIC, diisopropylcarbodiim...

Scheme 2.5 Organocatalytic epoxidation of unsaturated aldehydes and ketones ...

Scheme 2.6 Epoxidation of an unsaturated ketone with a primary amine catalys...

Scheme 2.7 Use of chiral aziridine

28

in the total synthesis of teleocidin B...

Scheme 2.8 Cu‐catalyzed aziridination in the total synthesis of agelastatin ...

Scheme 2.9 Aziridine formation via nucleophilic displacement in the synthesi...

Scheme 2.10 Aziridination of imines with sulfur ylides in the total synthesi...

Scheme 2.11 Synthesis of azetidines using azabicyclo[1.1.0]butyllithium. THF...

Scheme 2.12 Organocatalytic desymmetrizing opening of racemic azetidines.

Scheme 2.13 Cu‐catalyzed Kinugasa reaction for the synthesis of azetidinones...

Scheme 2.14 Rh–Pd‐catalyzed formation of β‐lactams via C‐H activation and al...

Scheme 2.15 Formation of chiral pyrrolidine building block

79

. DCE, 1,2‐Dich...

Scheme 2.16 Preparation of chiral pyrrolidine

86

by dipolar cycloaddition....

Scheme 2.17 Pyrrolidine building block

90

obtained by Au‐catalyzed cycloizom...

Scheme 2.18 Synthesis of spirooxindol pyrrolidine

95

. DCE, 1,2‐Dichloroethan...

Scheme 2.19 Organocatalytic synthesis of chiral pyrrolidines with antibacter...

Scheme 2.20 Rh‐catalyzed synthesis of pyrrolidine building block

105

.

Scheme 2.21 Ir‐catalyzed dearomatization of indoles in the total synthesis o...

Scheme 2.22 Organocatalytic synthesis of spirooxindol intermediate

116

.

Scheme 2.23 Spirooxindol

122

in the total synthesis of (−)‐strychnofoline....

Scheme 2.24 Chiral pyrrolidine building block

125

obtained via enantioselect...

Scheme 2.25 Chiral lactone

130

in the total syntheses of amprenavir and empa...

Scheme 2.26 Chiral pyrrolidine

135

in the total synthesis of swainsonine. TE...

Scheme 2.27 Building block

143

for peptide ligation.

Scheme 2.28 Intermediate

146

in the total synthesis of (−)‐deoxoapodine.

Scheme 2.29 Pd‐catalyzed allylic substitution for the synthesis of derivativ...

Scheme 2.30 Ni‐catalyzed synthesis of piperidine building block

156

.

Scheme 2.31 General preparation of bisalkaloid ligands (a) and its applicati...

Figure 2.1 Examples of chiral catalysts derived from

Cinchona

alkaloids.

Chapter 3

Scheme 3.1 Alkylation of (

S

)‐prolinolamides.

Scheme 3.2 Stereoselective acyl‐Claisen rearrangement as a key step in synth...

Scheme 3.3 Rearrangement of chiral amide

8

to butyrolactone

9

.

Scheme 3.4 Asymmetric Michael addition to conjugated amides.

Scheme 3.5 Synthesis of (−)‐α‐elemene (

19

).

Scheme 3.6 Diastereoselective Eschenmoser–Claisen rearrangement of glycine d...

Scheme 3.7 Diastereoselective thio‐Claisen rearrangement of glycine derivati...

Scheme 3.8 Asymmetric acyl‐Claisen rearrangement of allylamines.

Scheme 3.9 Asymmetric radical reactions.

Scheme 3.10 Conformations of aza‐enolates and stereochemical model of the re...

Scheme 3.11 α‐Functionalization of Enders' hydrazones with various electroph...

Scheme 3.12 Cleavage of hydrazine moiety.

Scheme 3.13 Nucleophilic addition of organometallic species to C<span class=...

Scheme 3.14 Alkylation of α‐heteroatom substituted hydrazones.

Scheme 3.15 Total synthesis of 2‐

epi

‐deoxoprosopinine (

50

).

Scheme 3.16 Tandem aza‐Michael addition/α‐ester enolate alkylation or aldol ...

Scheme 3.17 Diastereoselective Staudinger [2+2] cycloaddition.

MMPP

 = 

magnes

...

Scheme 3.18 Nucleophilic addition to indoline‐derived chiral hydrazone.

Scheme 3.19 Diastereoselective radical addition to

N

‐acyl hydrazones.

Scheme 3.20 Evans' oxazolidinone as asymmetry inducer in a diastereoselectiv...

Scheme 3.21 Total synthesis of baulamycin A: synthesis of fragment

88

.

Scheme 3.22 Total synthesis of baulamycin A: synthesis of fragment

95

.

Scheme 3.23 Diels–Alder reaction of dienophile

107

.

Scheme 3.24 1,4‐Addition/enolate trapping of unsaturated amides bearing Oppo...

Scheme 3.25 Aldol reaction of

N

‐acylated Oppolzer's sultam with aldehydes....

Scheme 3.26 Examples of electrophilic α‐addition to

N

‐acylated Oppolzer's su...

Scheme 3.27 Aziridination with

N

‐alkoxycarbonyl imines with diazo reagent

11

...

Scheme 3.28 Alkylation of 2‐aza (

120

) and 3‐aza (

125

) camphor imides.

Scheme 3.29 Aldol reaction of

N

‐acyl camphor imide

128

.

Scheme 3.30 Alkylation reactions of

131

,

134,

and

135

with alkyl halides....

Scheme 3.31 Aldol reaction of

N

‐acylated camphor‐based oxazolidines.

Scheme 3.32 Asymmetric olefination of chiral phosphonamides.

Scheme 3.33 Alkylation of chiral phosphonamides.

Scheme 3.34 Asymmetric conjugated 1,4‐addition of phosphonamides to Michael ...

Scheme 3.35 Asymmetric 1,4‐addition of P‐chiral phosphonoamide to Michael ac...

Scheme 3.36 Nucleophilic addition to chiral

N

‐phosphonyl imines.

Scheme 3.37 Synthesis of the anti‐cancer drug velcade (

164

).

Scheme 3.38 Synthesis of Schöllkopf's chiral auxiliary.

Scheme 3.39 Asymmetric alkylation of bis‐lactim

166

.

Figure 3.1 Proline‐based chiral auxiliaries.

Figure 3.2 Examples of 2,5‐disubstituted pyrrolidine chiral auxiliaries.

Figure 3.3 Selected analogs of SAMP/RAMP hydrazines.

Figure 3.4 Selected analogs of Enders' proline‐based hydrazines.

Figure 3.5 Structure of

N

‐acyl hydrazones. LA = Lewis acid.

Figure 3.6 Selected Evans‐type chiral auxiliaries.

Figure 3.7 Structure of baulamycin A (

81

).

Figure 3.8 Camphor‐derived chiral auxiliaries.

Figure 3.9 Examples of phosphonamide chiral auxiliaries.

Figure 3.10 Heterocyclic analogs of Schöllkopf's auxiliary.

Chapter 4

Scheme 4.1 Resolution of the racemic

trans

‐1,2‐diaminocyclohexane.

Scheme 4.2 Asymmetric cyanation reactions.

TFAA

,

trifluoroacetic anhydride

...

Scheme 4.3 Michael additions of malonate to nitrostyrenes.

Scheme 4.4 Michael additions of other 1,3‐dicarbonyls to nitrostyrene.

Scheme 4.5 Michael additions of ketones to nitrostyrene.

Scheme 4.6 Michael additions of other carbon nucleophiles to nitrostyrene....

Scheme 4.7 Michael additions of heteroatom‐centered nucleophiles to nitrosty...

Scheme 4.8 Michael reactions of enones.

Scheme 4.9 Michael reactions of benzylidene pyruvates.

Scheme 4.10 Reactions of isatin‐derived Michael acceptors.

Scheme 4.11 Michael reactions of maleimides.

Scheme 4.12 Reaction of 4‐nitrobenzaldehyde with cyclohexanone.

Scheme 4.13 Asymmetric reactions of aldehydes.

DIPEA

,

diisopropylethylamine

....

Scheme 4.14 Enantioselective reactions of isatins.

Scheme 4.15 Enantioselective reactions of imines.

DABCO

,

1,4‐diazabicyclo[2.

...

Scheme 4.16 Asymmetric Pictet–Spengler‐type reactions.

Scheme 4.17 Reactions of nitrogen electrophiles.

Scheme 4.18 Miscellaneous reactions.

LED

,

light emitting diode

;

Scheme 4.19 Miscellaneous cyclizations and cycloadditions.

Figure 4.1 Early examples of

trans

‐1,2‐diaminocyclohexane‐based organocataly...

Figure 4.2 Examples of protected DACH derivatives commonly used in the synth...

Figure 4.3 Selected

N

1,

N

1‐dialkyl‐cyclohexane‐1,2‐diamines used in organocat...

Figure 4.4 Mono‐amides (

4

) and sulfonamides (

5

).

Figure 4.5 Amine‐thiourea (

6

and

7

) and urea (

8

) derivatives.

Figure 4.6 Amine‐(thio)ureas containing two different chiral units.

Figure 4.7 Amine‐squaramide derivatives.

Figure 4.8 Organocatalysts containing a guanidine motif.

Figure 4.9 Non‐basic thiourea and urea organocatalysts activating via hydrog...

Figure 4.10 Tertiary ammonium salts‐ureas

17

for phase transfer catalysis....

Figure 4.11

C

2

symmetric mono‐DACH organocatalysts.

Figure 4.12 Organocatalysts containing two diaminocyclohexane units.

Figure 4.13 Amides of DACH with

N

‐unprotected amino acids.

Figure 4.14 Miscellaneous DACH‐based organocatalysts (

21

).

Chapter 5

Figure 5.1 Representative natural products containing 2,5‐diketopiperazine c...

Figure 5.2 Main strategies for the synthesis of 2,5‐DKPs.

Figure 5.3 Synthesis of 2,5‐DKPs from dipeptide esters.

Figure 5.4 Strategies for the synthesis of 2,5‐DKPs on solid supports. (a) S...

Figure 5.5 Synthesis of 2,5‐DKPs via the Ugi reaction: general concept.

Figure 5.6 Synthesis of 2,5‐DKPs via the Ugi reaction: representative practi...

Figure 5.7 Synthesis of 2,5‐DKPs by intramolecular aza‐Wittig reactions.

Figure 5.8 Synthesis of 2,5‐DKPs coupled to Pictet–Spengler reactions.

Figure 5.9 Synthesis of 2,5‐DKPs by intramolecular amide alkylation.

Figure 5.10 Synthesis of 2,5‐DKPs by a domino Ugi‐aza‐Michael sequence.

Figure 5.11 Synthesis of 2,5‐DKPs by dimerization of α‐haloacetamides.

Figure 5.12 An example of the synthesis of 2,5‐DKPs by one‐pot formation of ...

Figure 5.13 Biosynthesis of 2,5‐DKPs from aminoacyl‐tRNAs catalyzed by cyclo...

Figure 5.14 Two synthetic approaches to tadalafil. Reagents and conditions: ...

Figure 5.15 Synthesis of NNZ‐2591. Reagents and conditions: (i) CHCl

3

, reflu...

Figure 5.16 Synthesis of aplaviroc. Reagents and conditions: (i) (a) MeOH, 5...

Figure 5.17 Synthesis of retosiban. Reagents and conditions: (i) Triethylami...

Figure 5.18 Asymmetric synthesis of amino acids from 2,5‐DKPs.

Figure 5.19 Synthesis of tryprostatin B from cyclo(

L

‐Trp‐

L

‐Pro).

Figure 5.20 Synthesis of spirotryprostatin based on an intramolecular Heck r...

Figure 5.21 Synthesis of stephacidin B from a functionalized diketopiperazin...

Figure 5.22 Synthesis of versicolamide B via an intramolecular Diels–Alder r...

Figure 5.23 Synthesis of variecolortide A via an intermolecular Diels–Alder ...

Figure 5.24 Synthesis of dideoxyverticillin A from a protected cyclo(

L

‐Trp‐

L

Figure 5.25 Total synthesis of ardeemin and

N

‐acetylardeemin.

Figure 5.26 Total synthesis of (+)‐phakellin based on an Overman rearrangeme...

Figure 5.27 Synthesis of sarcodonin ɛ and phellodonin from a common diketopi...

Figure 5.28 Fukaiyama's total synthesis of ecteinascidin 743 from an Ugi‐der...

Chapter 6

Scheme 6.1 Synthesis of (

S

)‐harmicine using

L

‐proline as a chiral pool subst...

Scheme 6.2 Synthesis of 4‐phosphothiophen‐2‐yl alanine using a serine‐derive...

Scheme 6.3 Synthetic pathway for the asymmetric synthesis of the (

R

)‐lacosam...

Scheme 6.4 Synthesis of a novel thiazoline derivative starting from

L

‐threon...

Scheme 6.5 Asymmetric synthesis of sarpagine and koumine alkaloids using

L

‐t...

Scheme 6.6 Retrosynthetic strategy to tubulysins starting from

L

‐valinol and...

Scheme 6.7 Stereoselective syntheses of (2

R

)‐pterosin B using the chiral aux...

Scheme 6.8 Stereoselective synthesis of novel FTY720 analogues using Schöllk...

Scheme 6.9 Synthesis of (+)‐ambrisentan using the diastereoselective Evans' ...

Scheme 6.10 Retrosynthesis of presaccharotriolide Z.

Scheme 6.11 Synthesis of the chiral aldehyde and vinyl iodide intermediates ...

Scheme 6.12 SuperQuat chiral auxiliaries introduced by Davies' group.

Scheme 6.13 Synthesis of α‐chiral bicyclo[1.1.1]pentanes, using the Davies' ...

Scheme 6.14 The proline‐derived Corey–Bakshi–Shibata (CBS) catalyst.

Scheme 6.15 The key proline‐catalyzed aldol reaction in the total synthesis ...

Scheme 6.16 The use of prolinate salts for a multi‐component Mannich reactio...

Scheme 6.17 Tandem‐type one‐pot process of an aldol proline‐amide‐catalyzed ...

Scheme 6.18 The use of ball milling in the proline‐based thiodipeptide catal...

Scheme 6.19 Organocatalyzed conjugate additions of aldehydes to nitroolefins...

Scheme 6.20 Novel diarylprolinol‐derived amino perfluoroalkanesulfonamide ca...

Scheme 6.21 The total synthesis of clinprost via a key diarylprolinol silyl ...

Scheme 6.22 Vinylogous Michael Aldol cascade for the synthesis of spirocycli...

Scheme 6.23 Enantioselective radical conjugate addition to enals using a org...

Scheme 6.24 One‐pot sequential bio‐catalyzed oxidation/organocatalyzed α‐ary...

Scheme 6.25 Highly stereoselective [4+2]‐cycloaddition reaction of activated...

Scheme 6.26 The key highly stereoselective organocatalyzed asymmetric epoxid...

Scheme 6.27 The synthesis of calcimimetic (

R

)‐(+)‐NPS R‐568 via a one‐pot im...

Scheme 6.28 Direct asymmetric aldol reaction between cycloalkanones and subs...

Scheme 6.29 Proline and visible‐light organophotoredox strategy for an enant...

Scheme 6.30 Postulated mechanism for the enantioselective Mannich reaction o...

Scheme 6.31 The key α‐arylation using an Olofsson diaryliodonium salt and a ...

Scheme 6.32 A flow‐chemistry‐assisted highly stereoselective 1,3‐dipolar cyc...

Scheme 6.33 Cascade cyclizations of α,β‐unsaturated thioesters leading to in...

Figure 6.1 The original Hajos, Parrish, Wiechert, Eder, and Sauer reaction, ...

Figure 6.2 (a) Birmann's first‐generation 2,3‐dihydroimidazo[1,2‐

a

]pyrimidin...

Chapter 7

Scheme 7.1 The variety of asymmetric reactions involving Kunz auxiliary as a...

Scheme 7.2 The Mannich reaction selectivity difference in relation to the ty...

Scheme 7.3 Stereoselective 1,4‐addiction combined with enolate

30

trapping v...

Scheme 7.4 Stereoselective Diels‐Alder reaction of

27b

and

28b.

Scheme 7.5 Stereoselective epoxidation of oxazolidine‐based alkene

34.

Scheme 7.6 The reversed selectivity for

36

that depends on R

1

substituent ty...

Scheme 7.7 The conformational explanation of observed stereoselectivity diff...

Scheme 7.8 Stereoselective 1,4‐addition of a radical to

Aux

5d

crotonate (

38

...

Scheme 7.9 Stereoselective dihydroxylation of double bond of crotonate

38c.

...

Scheme 7.10 1,3‐dipolar cycloaddition involving the sugar‐auxiliary develope...

Scheme 7.11 Application of

allo

‐furanose derivative

56

as a chiral auxiliary...

Scheme 7.12 The aldol reaction supported by the sugar‐derived auxiliary

58

d...

Scheme 7.13 The stereoselective benzylation of ester

61

reported by Kakinuma...

Scheme 7.14 The Tadano's approach for alkylation of esters with auxiliary

Au

...

Scheme 7.15 The Tadano's approach for dialkylation of β‐ketoesters with auxi...

Scheme 7.16 Ferrocene selective iodination with application of sugar‐based a...

Scheme 7.17 Sugar‐based ether auxiliaries application in [2+1] cycloaddition...

Scheme 7.18 Sugar‐based ether auxiliaries application in [2 + 4] cycloadditi...

Scheme 7.19 Stereoselective singlet oxygen addition to naphthalene ring.

Scheme 7.20 Stereoselective hydrogenation of the double bond.

Scheme 7.21 Stereoselective reduction of the carbonyl group.

Scheme 7.22 Sugar‐based diphosphinite derivatives utilized in the asymmetric...

Scheme 7.23 Structures of catalysts

90a

and

90b

and their pseudo‐enantiomeri...

Scheme 7.24 The asymmetric addition of cyanide to a vinylnaphthalene promote...

Scheme 7.25 Structures of carbohydrate‐based Trost ligands

93–95

and t...

Scheme 7.26 The Woodward application of ligand

95

in the copper initiated Mi...

Scheme 7.27 The asymmetric cyanosiliation of ketones promoted by chiral comp...

Scheme 7.28 The asymmetric allylic alkylation of

103

and

104

catalyzed by su...

Scheme 7.29 Sugar‐derived BOX ligands and their application in the asymmetri...

Scheme 7.30 The asymmetric alkynylation of imines catalyzed by Cu/

113

compl...

Scheme 7.31 The asymmetric hydrogenation of olefins catalyzed by Ir/

116

com...

Scheme 7.32 The asymmetric Heck reaction catalyzed by Pd/

121

complexes.

Scheme 7.33 The NHC induced hydrosilylation of ketones.

Scheme 7.34 The Shi epoxidation of olefins initiated by chiral ketones

130

Scheme 7.35 The asymmetric Michael addition to nitroolefins

147

catalyzed by...

Scheme 7.36 The asymmetric addition of

150

to imine

151

promoted by urea

145

...

Scheme 7.37 The asymmetric cyanosilylation of benzylophosphonates

153

cataly...

Scheme 7.38 The oxidative spirolactonization of

157

promoted by sugar‐derive...

Scheme 7.39 The phase transfer catalyzed epoxidation of chalcone

160

with su...

Figure 7.1 The pseudo‐enantiomeric relation of

D

‐galactose and

D

‐arabinose....

Figure 7.2 The examples of Kunz auxiliaries based on

D

‐galactose (

1

),

D

‐arab...

Figure 7.3 Examples of sugar‐derived auxiliaries used in ester forms.

Figure 7.4 Selected examples of sugar‐based organocatalysts containing a pr...

Figure 7.5 The examples of phase transfer catalysts

161–165

derived fr...

Chapter 8

Scheme 8.1 Biosynthesis of terpenes shown on the example of verbenone

5

, men...

Scheme 8.2 Synthesis of (+)‐artemone

22

and (−)‐cyclonerodiol

26

, chokol G

2

...

Scheme 8.3 Synthesis of ophiobolins A and N.

Scheme 8.4 Synthesis of (+)‐neopeltolide

53

employing citronellol

43

.

Scheme 8.5 Citronellol and citronellene as starting material in the synthesi...

Scheme 8.6 Synthesis of the tricyclic core

64

of the pseudopteroxazole.

Scheme 8.7 Examples of natural products obtained using carvone‐derived chira...

Scheme 8.8 Synthesis of (+)‐cubitene

85

through the SmI

2

‐induced cyclization...

Scheme 8.9 Synthesis of precursor

91

as the precursor of

Abies

sesquiterpeno...

Scheme 8.10 Synthesis of (+)‐cyperolone

97

utilizing (

R

)‐(−)‐carvone

72

as t...

Scheme 8.11 Transformation of (

R

)‐(−)‐carvone epoxide

99

to [3.3.1]bicyclic ...

Scheme 8.12 Synthesis of aciphyllene

111

based on the (

R

)‐(+)‐limonene

106

c...

Scheme 8.13 Diels–Alder cycloaddition of limonene‐derived ketone

114

leading...

Scheme 8.14 Limonene‐derived allylic alcohol

117

as a precursor of sesquiter...

Scheme 8.15 Transformation of (

S

)‐(−)‐limonene

123

to wine lactone

124

and (...

Scheme 8.16 (

S

)‐(−)‐perillyl alcohol

126

as starting material in the synthes...

Scheme 8.17 Utility of (

R

)‐(+)‐perillyl alcohol‐derived β‐ketoester

130

in t...

Scheme 8.18 (

R

)‐(+)‐Pulegone

134

as substrate in the synthesis of jiadifenol...

Scheme 8.19 (

S

)‐(−)‐Pulegone

139

as substrate in the synthesis of (+)‐ryanod...

Scheme 8.20 Synthesis of (−)‐englerin A

151

starting from (1

R

,3

R

,4

S

)‐(−)‐iso...

Scheme 8.21 (1

R

,3

R

,4

S

)‐(−)‐Isopulegol

139

as starting material in the synthe...

Scheme 8.22 (1

R

,3

R

,4

S

)‐(−)‐Isopulegol

146

transformation to an alkaloid benz...

Scheme 8.23 Utility of (−)‐menthone

161

as a chiral reactant.

Scheme 8.24 Transformation of (1

S

,6

R

)‐(+)‐3‐carene

167

to ingenane and tigli...

Scheme 8.25 Utility of (1

S

,6

R

)‐(+)‐2‐carene

174

to construct a

gem

‐dimethylc...

Scheme 8.26 Synthesis of guadials B

186

and C

187

using (+)‐α‐

184

and (−)‐β...

Scheme 8.27 Utility of (1

R

,5

R

)‐(+)‐verbenone

188

in the synthesis of (+)‐ono...

Scheme 8.28 Synthesis of (+)‐cardamon peroxide

203

commenced from (1

R

,5

S

)‐(−...

Scheme 8.29 Transformation of (1

S

,4

R

)‐(+)‐fenchone

204

to a 5,7‐fused ring p...

Figure 8.1 Acyclic monoterpenes most frequently used as chiral pool.

Figure 8.2 Monocyclic monoterpenes most frequently used as chiral pool.

Figure 8.3 Guaiane‐type sesquiterpenoides obtained from (

R

)‐(+)‐limonene

106

Figure 8.4 Bicyclic monoterpenes most frequently used as chiral pool.

Chapter 9

Scheme 9.1 Synthesis of chrysolic acid methyl esters

5

and isofregenedol

6

....

Scheme 9.2 Synthesis of labdane diterpenoids from zamoranic acid,

1

.

Scheme 9.3 Synthesis and synthetic plan of drimanes from zamoranic acid.

Scheme 9.4 Isodrimeninol synthesis from zamoranic acid.

Scheme 9.5 Limonidilactone,

49

, synthesis from zamoranic acid.

Scheme 9.6 Synthesis of angeloyl‐gutierrezianolic acid methyl ester from zam...

Scheme 9.7 Synthesis for tri‐ and tetracyclic diterpenes from zamoranic acid...

Scheme 9.8 Synthesis of tricyclic key intermediates from zamoranic acid.

Scheme 9.9 Synthesis of natural

ent

‐halimanolide from

ent

‐halimic acid,

2

.

Scheme 9.10 Synthesis of α and β‐hydroxyhalimanolides.

Scheme 9.11 Synthesis of furo‐

ent

‐halimanolides.

Scheme 9.12 Synthesis of chettaphanins from

ent

‐halimic acid.

Scheme 9.13 Synthesis of sesterterpenolides.

Scheme 9.14 Synthesis of sesterterpenolide analogues of dysidioide.

Scheme 9.15 Synthesis of

ent

‐labdanes from

ent

‐halimanes.

Scheme 9.16 Synthesis of pricrasane and abeopicrasane from

ent

‐halimic acid,...

Scheme 9.17 Synthesis of [4.3.3]propellanes from

ent

‐halimic acid,

2

.

Scheme 9.18 Synthesis of sesquiterpenes quinone/hydroquinone.

Scheme 9.19 Synthesis of (+)‐agelasine C.

Scheme 9.20 Synthesis of (+)‐thiersindole C,

131

, from

ent

‐halimic acid,

2

....

Scheme 9.21 Synthesis of sesquiterpenyl‐indoles from

ent

‐halimic acid.

Figure 9.1 Natural products zamoranic acid,

1

, and

ent

‐halimic acid,

2

, isol...

Figure 9.2 Synthesized compounds using zamoranic acid

1

as starting material...

Figure 9.3 Tri‐ and tetracyclic diterpene skeletons.

Figure 9.4 Synthesis of interesting compounds from

ent

‐halimic acid.

Figure 9.5 Sesterterpenolide and glycerol hybrids.

Figure 9.6 Natural quinone/hydroquinone sesquiterpenes.

Figure 9.7 Structures proposed and revised for (−)‐agelasine C and epi‐agela...

Figure 9.8 Sesquiterpene indoles, analogues of polyalthenol and pentacyclind...

Chapter 10

Scheme 10.1 Ring distortion of yohimbine with a subsequent decoration of fra...

Scheme 10.2 Synthesis of regulatory free pseudoephenamine substitute of pseu...

Scheme 10.3 Ephedrine isomers as chiral building blocks.

Scheme 10.4 Asymmetric addition of terminal alkynes to carbonyls mediated by...

Scheme 10.5 Selected examples of ligands and catalysts derived from ephedrin...

Scheme 10.6 Ephedrine‐derived amides

36

and

38

for enantio‐ or diastereosele...

Scheme 10.7 Selected applications of ephedrines‐derived heterocyclic chiral ...

Scheme 10.8 Synthesis of enantiomers of (

S

P

)‐

57

or (

R

P

)‐

59

from (−)‐ephedr...

Scheme 10.9 Regioselective substitution of pyridine ring in (

S

)‐nicotine

61

....

Scheme 10.10 (

S

)‐Nicotine as building block for related alkaloids: altinicli...

Scheme 10.11 Anabasine used as a chiral scaffold in various syntheses.

Scheme 10.12 Sparteine‐mediated asymmetric deprotonation of Hoppe carbamates...

Scheme 10.13 Aggarwal iterative asymmetric deprotonation mediated by spartei...

Scheme 10.14 Selected examples of (−)‐sparteine

88

‐mediated enantioselective...

Scheme 10.15 Sparteine‐mediated

ortho

‐lithiation for the synthesis of planar...

Scheme 10.16 (−)‐Sparteine

88

and (+)‐sparteine surrogate

91

‐mediated asymme...

Scheme 10.17 Synthesis of (+)‐sparteine surrogate

91

and other bispidines fr...

Scheme 10.18 Cytisine as a building block for synthesis of (+)‐hupeol

131

an...

Scheme 10.19 Major applications of Cinchona alkaloid derivatives

137

144

(i...

Scheme 10.20 Stoichiometric chiral sulfinyl transfer complex derived from qu...

Scheme 10.21 Ring cleavages and rearrangements of Cinchona alkaloids.

Scheme 10.22 Chiral building blocks from Cinchona alkaloids through an oxida...

Scheme 10.23 Ring distortion of quinine toward chiral molecular diversity....

Scheme 10.24 Nucleophilic substitution of Cinchona alkaloids.

Scheme 10.25 Baran's zinc sulfinates for radical regioselective modification...

Scheme 10.26 Selected examples of CH‐alkylation of Cinchona alkaloids using ...

Scheme 10.27 Formation of scopoline and epibatidine analog form scopolamine....

Scheme 10.28 Cocaine as a precursor of

cis

‐2,5‐disubstituted pyrrolidine der...

Scheme 10.29 Preparation of tropaquiniclidines

199–202

from cocaine by...

Scheme 10.30 Mizoroki–Heck polymerization of Cinchona alkaloid dimers with t...

Scheme 10.31 Quaternization of Cinchona bis 9‐

O

‐ethers toward polymers

206

....

Scheme 10.32 Immobilization of Cinchona organocatalysts onto poly(glycidyl m...

Figure 10.1 Selected alkaloids presented in this chapter and their applicati...

Figure 10.2 Ephedrine and its stereoisomers.

Figure 10.3 Selected applications of Myer's alkylation in total synthesis of...

Figure 10.4 Most common tobacco alkaloids.

Figure 10.5 Structural features and common representatives of lupin alkaloid...

Figure 10.6 Examples of biologically active compounds prepared with the use ...

Figure 10.7 Four major members of Cinchona alkaloids. Highlighted in gray ar...

Figure 10.8 Click chemistry Cinchona alkaloids‐derived 1,2,3‐triazoles and t...

Figure 10.9 Selected examples of biologically active diversified Cinchona al...

Figure 10.10 The most common members of tropane alkaloids.

Figure 10.11 Examples of hyperbranched polymers with Cinchona squaramide moi...

Figure 10.12 Helical poly(phenylacetylene)s

209–212

bearing Cinchona a...

Chapter 11

Scheme 11.1 The synthesis of

CBB 1

. Abbreviations:

NBS

 = 

N‐bromosuccinimide

...

Scheme 11.2 The synthesis of estrone.

Scheme 11.3 The synthesis of steroid system via

CBB 2

. Abbreviations: DIPEA ...

Scheme 11.4 The enantioselective synthesis of oxy‐functionalized steroids. A...

Scheme 11.5 The synthesis of cardiotonic steroids intermediate via

CBB 4

.

Scheme 11.6 The synthesis of cardenolide via

CBB 5

. Abbreviations: TPY = (tr...

Scheme 11.7 The synthetic approach to ouabagenin from

CBB 5

.

Scheme 11.8 The synthesis of

CBB 6

. Abbreviations: LDA = lithium diisopropyl...

Scheme 11.9 The synthesis of a tetracyclic steroidal core from

CBB 6

. Abbrev...

Scheme 11.10 The synthesis of an estrogenic skeleton from

CBB 7

.

Scheme 11.11 The synthesis of a steroid analogue via

CBB 8

; (a) (i) Phenylpr...

Scheme 11.12 The synthesis of

ent

‐steroids from

ent

CBB 8

.

Scheme 11.13 The synthesis of a steroidal precursor from

CBB 9

[15].

Scheme 11.14 Possible mechanism of the oxidative rearrangement [14]. Abbrevi...

Scheme 11.15 (a) The structure of cyclopamine; (b) the structure of Comins r...

Scheme 11.16 The synthesis of cyclocitrinol. Abbreviation: Ts = tosyl, DMAP ...

Scheme 11.17 The synthesis of vulgarobufotoxin. Abbreviations:

TBS

 = 

tert‐bu

...

Scheme 11.18 The synthesis of pleurocin A/matsutakone. Abbreviations:

CSA

 = 

Scheme 11.19 The synthesis of strophasterol. Abbreviations: DMAP = 4‐dimethy...

Scheme 11.20 The synthesis of herbarulide. Abbreviation: MCPBA = 

meta

‐chloro...

Scheme 11.21 The synthesis of pinnigorgiol E and pinnigorgiol B. Abbreviatio...

Scheme 11.22 The synthesis of clathsterol. Abbreviations: TBS = 

tert

‐butyldi...

Scheme 11.23 The synthesis of propindilactone G. Abbreviations:

IBA

 = 

3‐iodo

...

Figure 11.1 (a) The steroid skeleton; (b) cholesterol structure with carbon ...

Figure 11.2 Examples of substrates from the chiral pool used to synthesize s...

Figure 11.3 The structure of (a) Hajos–Parish ketone and (b) Wieland–Miesche...

Chapter 12

Scheme 12.1 Synthesis of

H

‐Phosphinate (

R

P

)‐

7

.

Scheme 12.2

L

‐Menthyl

H

‐phosphinates in the construction of

P

‐stereogenic co...

Scheme 12.3 The utility of dimenthyl phosphite

26

in the synthesis of

28

and...

Scheme 12.4 The transformation of

30

leading to (−)‐menthyl phenylphosphinat...

Scheme 12.5 The synthesis of numerous chiral organophosphorus compounds from...

Scheme 12.6 Synthesis of

L

‐menthyl

H

‐phosphinite‐boranes and

L

‐menthyl

H

‐pho...

Scheme 12.7 Functionalization in the 3,3′‐positions.

Scheme 12.8 Functionalization in the 4,4′‐positions.

Scheme 12.9 Polymer supported 4,4′‐substituted‐BINAP‐based ligands. DVB, div...

Scheme 12.10 Functionalization in the 5,5′‐positions. DMSO, dimethyl sulfoxi...

Scheme 12.11 Modification of MeO‐BIPHEP.

Scheme 12.12 Modification of HO‐BIPHEP.

Scheme 12.13 Modification of positions 6 and 6′ of biphenyl core. MW, microw...

Scheme 12.14 Modification of biphenyl‐derived phosphepines.

Scheme 12.15 The enzymatic transformation of

191

leading to dehydrophos (DHP...

Scheme 12.16 The synthesis of glucosides and galactosides

199–200

.

Scheme 12.17 The synthesis of

R

and

S

1,2,3,4‐tetrahydroisoquinoline‐3‐phosp...

Scheme 12.18 The synthesis of a library of α‐aminophosphonic acids

207

and

2

...

Scheme 12.19 The formation of deoxynucleotide derivatives

211–213

.

Scheme 12.20 The synthetic route to GGsTop

217

.

Scheme 12.21 The synthesis of aminophosphonic acids

222–223

.

Scheme 12.22 The synthesis of tRNASec mimic

228

.

Scheme 12.23 The synthetic route to receptor antagonists

240–242

and p...

Scheme 12.24 The steps of the synthesis of the inhibitor prodrug

246

.

Scheme 12.25 The synthesis of dipeptide

251

starting from

247

.

Scheme 12.26 The synthesis of a library of peptides

256–259

.

Scheme 12.27 Aminophosphonic acid

253

as a building block for peptide

261

.

Scheme 12.28 Fmoc‐

L

‐BrPmp(OMe

2

)‐OH

262

as a building block for the tripeptid...

Scheme 12.29

N

‐Fmoc‐F

2

Pmp‐OH

264

as a building block for peptides

265

and

26

...

Scheme 12.30 Formation of imine

269

starting from

267

.

Scheme 12.31 The synthesis of α‐epoxy‐δ‐aminophosphonate

273

.

Scheme 12.32 The synthesis of amino‐β‐ketophosphonate (

R

)‐

274

starting from...

Scheme 12.33 The synthesis of two natural peptides: Rhizocticin A and Plumbe...

Scheme 12.34 Synthesis chiral cyclic triamides or diamidochloridites.

Scheme 12.35 Total synthesis of estrone

289

.

Scheme 12.36 Synthesis of enantiopure phosphino‐phosphonites.

Scheme 12.37 Stereoselective formation of aminophosphines.

Scheme 12.38 The asymmetric synthesis of numerous chiral organophosphorus co...

Scheme 12.39 Synthesis of primary aminophosphines.

Scheme 12.40 Diastereoselective formation of

N

‐phosphinoyl oxazolidinones....

Scheme 12.41 Ephedrine‐assisted formation of chiral phosphorous stereocenter...

Scheme 12.42 Pseudoephedrine derived

bis

‐P‐chiral scaffolds.

Scheme 12.43 Acid‐dependent formation of secondary phosphine oxide antipodes...

Scheme 12.44 1‐Amino‐2‐indanol assisted synthesis of chiral

sec

‐Phosphine ox...

Scheme 12.45 Diastereoselective

ortho

‐lithiation of ferrocene

325

.

Figure 12.1 (−)‐

L-

Menthol in the synthesis of

P

‐stereogenic compounds.

Figure 12.2 Optically pure

L

‐menthyl phosphinates.

Figure 12.3

P

‐Stereogenic phosphonium salt and phosphine oxides.

Figure 12.4 (−)‐Menthol‐derived catalysts

48

57

.

Figure 12.5 Structures of atropisomeric phosphine ligands.

Figure 12.6 Polymeric and dendrimeric of 5,5′‐disubstituted BINAP derivative...

Figure 12.7 Modification of BINAPINE.

Figure 12.8 “Envelope” representation of aminophosphonate pentamolybdate uni...

Figure 12.9 Organophosphorus compound with P—N and/or P—O bonds.

Chapter 13

Scheme 13.1 Classical synthesis of menthyl (

S

S

)‐

p

‐toluenesulfinate.

Scheme 13.2 Alternative synthesis of menthyl (

S

S

)‐

p

‐toluenesulfinate.

Scheme 13.3 Synthesis of alkyl or aryl

p

‐tolyl sulfoxides by using menthyl (

Scheme 13.4 Highly successful synthetic strategies from past works involving...

Scheme 13.5 First steps involving chiral sulfinyl compounds in the synthesis...

Scheme 13.6 Relevant chiral intermediates in the synthesis of octalactins.

Scheme 13.7 Synthesis of chiral dihydropirans.

Scheme 13.8 Synthesis of (

R

)‐crispine A.

Scheme 13.9

ortho

‐Lithiation of activated aryl fragments as an innovative nu...

Scheme 13.10 Chiral sulfinyl intermediates in the synthesis of (

S

)‐tetrahydr...

Scheme 13.11 Chiral sulfinyl intermediates in the synthesis of xylopinine. S...

Scheme 13.12 Chiral sulfinyl quinonoid structures.

Scheme 13.13 Sulfinyl‐based synthesis of the core of ajudazol. Source: Essig...

Scheme 13.14 Chiral sulfoxides in the synthesis of atropisomeric structures....

Scheme 13.15 A sulfinyl route for the synthesis of steganone. Source: Dherba...

Scheme 13.16 Synthesis of chiral 2‐(

p

‐tolylsulfinyl)aniline.

Scheme 13.17 Homologation of boronic esters with chiral sulfinyl compounds....

Scheme 13.18 A sulfoxide‐oxazoline ligand.

Scheme 13.19 Synthesis of

p

‐toluenesulfinamide and its conversion into the c...

Scheme 13.20 First synthetic steps in the synthesis of (

S

)‐(+)‐cocaine.

Scheme 13.21 Application of the enolate of a Weinreb's amine in the synthesi...

Scheme 13.22 An early step in the synthesis of lirinine. Source: Hellal et a...

Scheme 13.23 An early step in the synthesis of lythranidine. Source: Gebauer...

Scheme 13.24 An early step in the synthesis of serine protease inhibitors.

Scheme 13.25 An early step in the synthesis of ibrexafungerp.

Scheme 13.26 A different menthyl arylsulfinate.

Scheme 13.27 Chiral sulfinyl ligands.

Scheme 13.28 Synthesis of (

S

)‐

tert

‐butyl

tert

‐butanethiosulfinate.

Scheme 13.29 Basic reactivity of the Ellman's reagent.

Scheme 13.30 Synthesis of a precursor of (+)‐yangambin with the aid of the E...

Scheme 13.31 Spiroketal intermediates with the aid of the Ellman's reagent....

Scheme 13.32 An early step in the synthesis of Almorexant.

Scheme 13.33 An early step in the synthesis of an inhibitor of

Pseudomonas a

...

Scheme 13.34 Chiral methyl phenyl sulfoximine as a precursor of thioureas.

Scheme 13.35 Chiral sulfoximines as a precursor of chiral cyclopropanes.

Scheme 13.36 Diacetone‐

D

‐glucose sulfinates and their employment in asymmetr...

Scheme 13.37 DAG‐sulfinates as precursor of rimatandine.

Scheme 13.38 Enantioselective oxidation of a large family of aryl benzyl sul...

Chapter 14

Scheme 14.1 Chiral diselenides in asymmetric synthesis.

Scheme 14.2 Selected examples of asymmetric methoxyselenylation of styrene....

Scheme 14.3 Chiral selenium‐mediated cyclization.

Scheme 14.4 Reagent‐controlled asymmetric selenocyclizations for the synthes...

Scheme 14.5 Selenium promoted synthesis of enantiopure pyrrolidines, octahyd...

Scheme 14.6 Possible conversions of selenium functionality.

Scheme 14.7 Asymmetric synthesis of substituted azetidines. THF, tetrahydrof...

Scheme 14.8 Synthesis of bioactive oligosaccharides.

Scheme 14.9 Asymmetric cyclopropanations of chiral methylene compounds with ...

Scheme 14.10 Synthesis of chiral 1,4‐dioxanes, morpholines, thiomorpholine, ...

Scheme 14.11 Synthesis of enantiopure pyrazino‐indoles and pyrroles. DCM, di...

Scheme 14.12 Functionalization of 2′,3′‐ene‐2′‐phenylselenonyl nucleosides t...

Scheme 14.13 A reactive selenosugar for the synthesis of enantiomerically pu...

Scheme 14.14 Vinyl selenones derived from

D

‐xylose and

D

‐fructose in diverse...

Scheme 14.15 Cycloaddition reactions of vinyl selenone‐modified carbohydrate...

Scheme 14.16 Organocatalyzed reactions for the preparation of densely functi...

Scheme 14.17 Organocatalyzed reaction of 2‐aryl‐2‐cyanoacetates and vinyl se...

Scheme 14.18 Total synthesis of (+)‐Trigonoliimine A.

Scheme 14.19 A key step for the total synthesis of Hinckdentine A.

Scheme 14.20 One‐pot enantioselective synthesis of 1,3‐oxazinan‐2‐one. PTSA,...

Scheme 14.21 Triple role of phenylselenonyl group.

Scheme 14.22 Enantioselective synthesis of quaternary α‐amino acids employin...

Scheme 14.23 Enantioselective vinylogous Michael addition to vinyl selenones...

Scheme 14.24 Organocatalyzed enantioselective Michael addition/cyclization c...

Scheme 14.25 Organocatalyzed Michael additions of oxindoles to vinyl selenon...

Figure 14.1 Selenium‐heteroatom nonbonding interaction.

Figure 14.2 Vinyl selenones as building blocks in asymmetric synthesis.

Chapter 15

Scheme 15.1 Axial chirality of allenes as the source of central chirality of...

Scheme 15.2 Enantiospecific, dialkylzinc‐initiated cyclization of 2,3‐alleno...

Scheme 15.3 The catalytic cycle transforming chiral propargyl mesylates into...

Scheme 15.4 Stereospecific reactions of chiral allenylzinc reagents with ena...

Scheme 15.5 Allenylmetal‐based approach to the enantioselective synthesis of...

Scheme 15.6 Face‐selective 1,2‐addition of Grignard reagents to chiral allen...

Scheme 15.7 Late‐stage construction of the spiroketal fragment of pectenotox...

Scheme 15.8 Bis(spirodiepoxide) strategy for the erythrynolide macrolactone ...

Scheme 15.9 The synthesis of chiral phosphine oxides by allene epoxidation....

Scheme 15.10 CT in Rh‐catalyzed nitrene addition to allene.

Scheme 15.11 Stereospecific aziridination of chiral allene.

Scheme 15.12 Cyclization of sulfamate‐allenes to bicyclic aziridines for the...

Scheme 15.13 Silylene transfer to chiral allene and ring expansion in the re...

Scheme 15.14 The concept of torquoselectivity controlled by axial chirality ...

Scheme 15.15 The synthesis of chiral methoxymethyl allenes and their enantio...

Scheme 15.16 Application of silver‐promoted allenol cyclization in synthesiz...

Scheme 15.17 Regio‐ and diastereospecific cyclization of allenediol in the s...

Scheme 15.18 The synthesis of (−)‐malyngolide.

Scheme 15.19 Formation of an iodonium cation from allene and its sulfoxide‐a...

Scheme 15.20 Intramolecular hydroarylation of chiral benzylallenes.

Scheme 15.21 Silver‐promoted

exo

cyclization of allenylamine.

Scheme 15.22 Enantiosepecific cyclization of allenols to vinyltetrahydrofura...

Scheme 15.23 Total synthesis of (−)‐rhazinilam.

Scheme 15.24 CT in intermolecular Au‐catalyzed hydroamination of allenes....

Scheme 15.25 Asymmetric intermolecular hydroarylation of allenes with

N

‐meth...

Scheme 15.26 Titanium‐mediated cyclization of allene‐ynes with the formation...

Scheme 15.27 Allenic Pauson–Khand reaction leading to 5,7‐bicyclic systems....

Scheme 15.28 Allenic Pauson–Khand reaction catalyzed by a cationic rhodium c...

Scheme 15.29 CT in C–H activation of methoxybenzamides followed by allenol i...

Scheme 15.30 Origin of enantiospecificity in Ni‐catalyzed reaction of allene...

Scheme 15.31 Photoinduced intramolecular [2+2] cycloaddition of allenes and ...

Scheme 15.32 Allene–alkene Diels–Alder route to (+)‐sterpurene.

Scheme 15.33 Intramolecular allene–diene Diels–Alder cycloaddition.

Scheme 15.34 Photocatalytic deracemization of allene and its enantiospecific...

Chapter 16

Scheme 16.1 Pioneering application of organocatalytic allylboration of keton...

Scheme 16.2 Stereoselective propargyl‐ and allylboration of hydrazonoesters ...

Scheme 16.3 Application of BINOL in asymmetric conjugated addition of triflu...

Scheme 16.4 Organocatalytic 1,6‐addition of arylboronic acids to para‐quinon...

Scheme 16.5 Stereoselective Petasis reaction by Marques and Burke. DCM, dich...

Scheme 16.6 Organocatalytic synthesis of trifluoromethyl allylboronic acids ...

Scheme 16.7 Asymmetric Michael addition catalyzed by BINOL‐based crown ether...

Scheme 16.8 Enantioselective benzylation of glycine derivative by Maruoka's ...

Scheme 16.9 Maruoka's hybrid phase‐transfer catalysis.

Scheme 16.10 Nucleophilic aromatic substitution catalyzed by BINOL‐based pho...

Scheme 16.11 Asymmetric nucleophilic fluorination under hydrogen bonding PTC...

Scheme 16.12 Michael reaction of indanone derivatives by Akiyama.

Scheme 16.13 Michael reaction/iminium ion cyclization by Dixon.

Scheme 16.14 Phospha‐Michael‐type addition by Terada.

Scheme 16.15 Aza‐Friedel–Crafts reaction by Terada. DCE, dichloroethane.

Scheme 16.16 Aza‐Friedel–Crafts reaction by Bolm. TFA, trifluoroacetic acid....

Scheme 16.17 Aza‐Diels–Alder reaction by Akyiama.

Scheme 16.18 Oxo‐Diels–Alder reaction by Terada.

Scheme 16.19 1,3‐Dipolar cycloaddition by Gong. DCM, dichloromethane; PCC, p...

Scheme 16.20 1,3‐Dipolar cycloaddition of azlactones and methyleneindolinone...

Scheme 16.21 Mannich‐type reaction presented by Akiyama.

Scheme 16.22 Mannich reaction of acetylacetone by Terada. DCM, dichlorometha...

Scheme 16.23 Alkylation of α‐diazoesters with

N

‐acylimines by Terada and Pen...

Scheme 16.24 The Biginelli reaction by Gong.

Scheme 16.25 Strecker reaction by Rueping. HCN, hydrogen cyanide.

Scheme 16.26 Reductive amination by MacMillan. MS, molecular sieves.

Scheme 16.27 Pictet–Spengler reaction by List.

Figure 16.1 BINOL and its derivatives.

Chapter 17

Figure 17.1 (a) Molecular structures of carbo[

n

]helicenes and helicene numbe...

Figure 17.2 Helicene topological descriptors.

Figure 17.3 Helicene scaffold embedded into large polycyclic aromatic system...

Figure 17.4 (a) Topological descriptor of the helicene chirality and ECD spe...

Figure 17.5 Racemic synthesis of carbo[

n

]helicenes: metal‐free photocyclizat...

Figure 17.6 Racemic synthesis of carbo[

n

]helicenes through Pd‐catalyzed reac...

Figure 17.7 Intramolecular Co‐, Ni‐, Ru‐, and Pt‐catalyzed [2+2+2] cyclizati...

Figure 17.8 Optical resolution strategies. (a) chiral agents used for recrys...

Figure 17.9 Selected examples of asymmetric synthesis from optically pure su...

Figure 17.10 Helicenes in catalysis.

Figure 17.11 Helicenes used for organic electronics.

Figure 17.12 Top: Chiral twistacenes.

Figure 17.13 (A) synthesis of

116

. Reagents and conditions: (a) (i) 2,6‐dibr...

Chapter 18

Figure 18.1

meso

‐Tetraaryl porphyrins (a) and

meso

‐tetraaryl‐2‐aza‐21‐carbap...

Figure 18.2 Chiral porphyrins, their complexes, and dimers.

Figure 18.3 Substitution and addition sites in modified

NCP

.

Figure 18.4 Two projections of enantiomers of

meso‐

tetraphenyl‐2‐aza‐2...

Figure 18.5 Enantiomers of 21‐alkylated

NCP

and their CD spectra of dichloro...

Figure 18.6 21‐substituted

NCP

and solid‐state structures of enantiomers of ...

Figure 18.7 Formation and reactivity of 2,21‐alkoxy

NCP

[65].

Figure 18.8 Application of N‐fused porphyrin in the synthesis of 21‐substitu...

Figure 18.9 Stereoisomers of internally bridged

NCP

derivatives: with 21,22‐...

Figure 18.10 Solid‐state structures of enantiomers (a), schematic structure ...

Figure 18.11 Enantiomers of 21‐(

o

‐carboxyphenyl)azo‐

NCP

(a) and 3‐amine‐21‐...

Figure 18.12 Enantiomers and CD spectra of 2‐methyl‐7,8‐(2′‐(2″,6″‐dichlorop...

Figure 18.13 Structures of chiral phlorins obtained by 1,3‐cycloadditions to...

Figure 18.14 Synthesis of 3‐P(O)(OEt)

2

–5‐H‐

NCP

(a), optical absorption (bla...

Figure 18.15 Examples of square planar and tetragonal bipyramid complexes of...

Figure 18.16 Schematic structures of chiral complexes of manganese, iron, co...

Figure 18.17 Schematic structure of zinc and cadmium complexes of 3‐P(O)(OR)...

Figure 18.18 Schematic representation and solid‐state enantiomers of the

NCP

Figure 18.19 Schematic structure and solid‐state enantiomers of

NCP

Ag(RuCp*)...

Figure 18.20 Schematic structures of 21‐ and 2,21‐alkylated derivatives of t...

Figure 18.21 Schematic structures and solid‐state enantiomers of selected

NC

...

Figure 18.22 Schematic and selected solid‐state structures of

NCP

dimers: bi...

Figure 18.23 Schematic and selected solid‐state structures of

NCP

dimers: bi...

Figure 18.24 Tetrakis(rhodium) bis(

NCP

) tetracarbonyl (a) and μ‐oxo‐dimer of...

Figure 18.25 Schematic structures of several chiral covalently bridged bis(

N

...

Figure 18.26 Schematic structures of silver(III) complex 2′,2″‐bis(3‐

NCP

Ag)...

Figure 18.27 Schematic and the solid state structures of 21,21′‐(

NCP

)

2

(a) a...

Figure 18.28 Definition of 3,3′‐(

NCP

)

2

chirality for the synclinal (a) and a...

Figure 18.29 Metal complexes of 3,3′‐(

NCP

)

2

with indication of their configu...

Chapter 19

Figure 19.1 Chemical structures of (a) the copper(I) complex [Cu(

1

)]

+

of...

Figure 19.2 Schematic representations and embedded presentations of the mole...

Figure 19.3 Chemical structure of porphyrin‐stoppered [2]rotaxane

3

.

Figure 19.4 Embeddings of the enantiomers of topologically chiral (a and b) ...

Figure 19.5 Chemical structures of conditionally topologically chiral [2]cat...

Figure 19.6 The chiral copper(I) [2]catenane complex [Cu(

7

)]

+

(one enant...

Figure 19.7 (a)

D

4

‐ and (b)

D

2

‐symmetric presentations of the Solomon rings ...

Figure 19.8 Schematical comparison of (a) a [2]catenane with oriented rings ...

Figure 19.9 Two isomers of the cyclodextrin‐based [2]rotaxane

10

:

10a

corres...

Figure 19.10 Inherently chiral [2]rotaxanes:

11

is based on the substitution...

Figure 19.11 The enantiomers of the “co‐conformationally point chiral” [2]ro...

Figure 19.12 Classical diagrams of the first five prime knots including the ...

Figure 19.13 Chemical structures of complexes of the molecular trefoil knots...

Figure 19.14 A molecular trefoil knot (

21

) obtained by hydrogen bond templat...

Figure 19.15 (a) Chiral and (b)

meso

diastereomers of a bis‐[2]catenane with...

Figure 19.16 (a) Chiral and (b)

meso

diastereomers of covalently linked tref...

Figure 19.17 A composite topologically chiral knot made by merging three ope...

Figure 19.18 A chiral bis[2]catenane (

22

) made by covalently bridging two to...

Figure 19.19 (a) A [3]rotaxane (

23

) incorporating two oriented macrocycles w...

Figure 19.20 Covalent bridging of trefoil knots produces knot‐stoppered dumb...

Figure 19.21 Chemical structure of the diastereomer of the branched tetrakno...

Figure 19.22 A covalent dimer of trefoil knots. The isomer shown (

27

) is chi...

Figure 19.23 A covalent trimer of trefoil knots. The isomer shown (

28

) is ch...

Figure 19.24 Copper(I) complexes of composite knots made by combining two do...

Figure 19.25 The dinuclear lutetium complex [Lu

2

(

30

)]

6+

of the composite...

Figure 19.26 Comparison of the structures of (a) the Fe

2+

complex of the...

Guide

Cover Page

Title Page

Copyright

Preface

Foreword

Table of Contents

Begin Reading

Index

Wiley End User License Agreement

Pages

iii

iv

xv

xvi

xvii

xix

xx

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

489

490

491

492

493

494

495

496

497

498

499

500

501

502

503

504

505

506

507

508

509

510

511

512

513

514

515

516

517

518

519

520

521

523

524

525

526

527

528

529

530

531

532

533

534

535

536

537

538

539

540

541

542

543

544

545

546

547

548

549

551

552

553

554

555

556

557

558

559

560

561

562

563

564

565

566

567

568

569

570

571

572

573

574

575

576

577

578

579

580

581

582

583

584

585

586

587

588

589

590

591

592

593

594

595

596

597

598

599

600

601

602

603

604

605

606

607

608

609

610

611

612

613

614

615

616

617

618

619

620

621

623

624

625

626

627

628

629

630

631

632

633

634

635

636

637

638

639

640

641

642

643

644

645

646

647

648

649

650

651

652

653

654

655

656

657

658

659

660

661

662

663

664

665

666

667

668

669

Chiral Building Blocks in Asymmetric Synthesis

Synthesis and Applications

 

Edited byElżbieta WojaczyńskaJacek Wojaczyński

 

 

Editors

Prof. Elżbieta WojaczyńskaWrocław University of Science and TechnologyFaculty of ChemistryWybrzeże Wyspiańskiego 1750 370 WrocławPoland

Dr. Jacek WojaczyńskiUniversity of WrocławFaculty of Chemistry14 F. Joliot‐Curie St.50 383 WrocławPoland

Cover Image: Courtesy of Prof. E. Wojaczyńska

All books published by WILEY‐VCH are carefully produced. Nevertheless, authors, editors, and publisher do not warrant the information contained in these books, including this book, to be free of errors. Readers are advised to keep in mind that statements, data, illustrations, procedural details or other items may inadvertently be inaccurate.

Library of Congress Card No.:applied for

British Library Cataloguing‐in‐Publication DataA catalogue record for this book is available from the British Library.

Bibliographic information published by the Deutsche NationalbibliothekThe Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data are available on the Internet at <http://dnb.d-nb.de>.

© 2022 WILEY‐VCH GmbH, Boschstraße 12, 69469 Weinheim, Germany

All rights reserved (including those of translation into other languages). No part of this book may be reproduced in any form – by photoprinting, microfilm, or any other means – nor transmitted or translated into a machine language without written permission from the publishers. Registered names, trademarks, etc. used in this book, even when not specifically marked as such, are not to be considered unprotected by law.

Print ISBN: 978‐3‐527‐34946‐3ePDF ISBN: 978‐3‐527‐83418‐1ePub ISBN: 978‐3‐527‐83419‐8oBook ISBN: 978‐3‐527‐83420‐4

Preface

The concept of chiral building blocks has emerged with the first total syntheses of natural products. Their complex architecture with a defined stereochemistry could be conveniently afforded with the use of enantiopure, easily available reactants: amino acids, carbohydrates, terpenes, simple alkaloids – compounds from a collection called a “chiral pool.” Their introduction at the early stage opens the route to stereoselective creation of subsequent stereogenic centers due to the possible chiral induction. The main drawbacks of this approach lie in the necessity of using stoichiometric amounts of chiral starting materials and in the fact that they are typically found in one enantiomeric form – limiting the accessible configuration of the target molecule.

Over the years, with the development of asymmetric synthesis, the attractiveness of building blocks has faded, as methods based on chiral, reusable auxiliaries, and catalysts (metal complexes, organic molecules, and enzymes) have gained popularity. Chirality multiplication resulting from the use of substoichiometric (“catalytic,” to use a common, but imprecise word) doses of such inducers, typically available as both optical antipodes, has captured the imagination of synthetic chemists. Their significance was also manifested by two Nobel Prizes awarded in 2001 to William S. Knowles, Ryōji Noyori, and K. Barry Sharpless for their work on stereoselective catalysis, and 20 years later to Benjamin List and David McMillan for the development of asymmetric organocatalysis.

It does not mean, however, that chiral pool concept has been completely forgotten or neglected. Perhaps pushed to the background by new discoveries and attracting less academic interest, it has always been of practical importance for the industry, in particular, for pharmaceutical companies exploiting all efficient and cheap routes for production of chiral drugs. For many preparations, the use of starting enantiomerically pure material is still the method of choice. And nowadays the chiral pool has been significantly enriched, to include not only compounds isolated from natural sources, but also simple synthetic building blocks, now available through efficient synthesis (sometimes combined with separation of enantiomers) or – more and more often – using biotechnological methods. They deliver both “natural,” traditional building blocks (amino‐ and hydroxyacids, terpenes, certain alkaloids) but also their less abundant enantiomers or diastereomers, and add new types of functionalities, e.g. amines or epoxides. A blend of approaches becomes common: reagents from the chiral pool often serve as the primary source of optical activity of many nonracemic compounds applied in catalytic processes, but, in turn, some of them are produced in asymmetric synthesis or with the use of enzymes. We hope that this book illustrates the current status of chiral building blocks in chemistry.

The book does not pretend to be comprehensive; instead of showing a full landscape, rather versatility and diversity of chiral building blocks are presented, from simple to complex ones, representing various types of chirality, originating from the presence of a stereogenic center (carbon atom or heteroatom), axis, or plane to helical and topological chirality. The authors – specialists in the field, some more experienced, and some at earlier stage of their careers – focus on the preparation of synthetic building blocks, and application of them as well as of natural chiral compounds in the construction of complex chiral scaffolds: drugs, agrochemicals, but also ligands and catalysts for organic synthesis.

We start with the smallest cyclic chiral building blocks, namely cyclopropene derivatives, whose stereoselective preparation is presented in Chapter 1. Two subsequent chapters focus on various ring systems containing heteroatoms: their preparation, and application as chiral reagents and auxiliaries. Again, there is no clear line between building blocks and auxiliaries: up to the moment when the chiral element remains in the product, it can be treated as a building block which may be eventually removed, but sometimes not entirely.